|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
20.800 -0.080 (-0.383%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 3.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -130.00 RMB (cts) | |
| Net Profit | -1,282.40 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -902.00 | -88.00 | 0 | -- | -839.00 | -917.00 |
| 2026 | -346.00 | -34.00 | 0 | -- | -315.00 | -451.00 |
| 2027 | -75.00 | -7.00 | 0 | -- | 92.00 | -242.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -917.00 | -89.00 | -- | CICC | Outperform | 36.98 | 29/08/2025 | |
| 2025 | -902.00 | -88.00 | -- | UBS | Neutral | 34.70 | 30/01/2026 | |
| 2025 | -839.00 | -84.00 | -- | JP MORGAN | Underweight | 20.00 | 02/02/2026 | |
| 2026 | -315.00 | -31.00 | -- | CICC | - | -- | 29/08/2025 | |
| 2026 | -346.00 | -34.00 | -- | UBS | - | -- | 30/01/2026 | |
| 2026 | -451.00 | -44.00 | -- | JP MORGAN | - | -- | 02/02/2026 | |
| 2027 | 92.00 | 9.00 | -- | UBS | - | -- | 30/01/2026 | |
| 2027 | -242.00 | -23.00 | -- | JP MORGAN | - | -- | 02/02/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 06/02/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -413,431 |
| %Change | -35.971% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 6.229 |